QS-7 Adjuvant
Platform Technology
Information
QS-7 saponin adjuvant has similar adjuvancy strength as QS-21, but with a reduced toxicity profile. Due to it's limited availability, it has not been extensively studied in human clinical trials. We aim to change that! Making QS-7 widely available to our vaccine research collaborators.